Author

Mathias Ilg

St. Anna Children's Cancer Research Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

Aleksandr OvsianikoviD· 1 shared Branka Radic-SarikasiD· 1 shared Caterina SturtzeliD· 1 shared Didier SurdeziD· 1 shared Florian HalbritteriD· 1 shared Heinrich KovariD· 1 shared Marica MarkovićiD· 1 shared Martha Magdalena ZylkaiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aleksandr OvsianikovORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Mevalonate pathway activation in Ewing sarcoma reveals a 3D-specific synergy between statins and BCL-xL inhibition

Branka Radic-Sarikas, Marica Marković, Martha Magdalena Zylka, Caterina Sturtzel, Mathias Ilg, Didier Surdez, Martin Lothar Metzelder, Martin Distel, Aleksandr Ovsianikov, Florian Halbritter, Heinrich Kovar

The paper develops a 3D culture platform for Ewing sarcoma and identifies a synergy between statins and BCL-xL inhibitors targeting the mevalonate pathway.

Molecular Therapy Oncology · May 9, 2026Peer-reviewedCancer Biology